{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T20:23:16Z","timestamp":1791663796825,"version":"4.3.4"},"reference-count":108,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,2,5]],"date-time":"2021-02-05T00:00:00Z","timestamp":1612483200000},"content-version":"vor","delay-in-days":370,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001807","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de S\u00e3o Paulo","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002322","name":"Coordena\u00e7\u00e3o de Aperfei\u00e7oamento de Pessoal de N\u00edvel Superior","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Brain, Behavior, and Immunity"],"published-print":{"date-parts":[[2020,2]]},"DOI":"10.1016\/j.bbi.2019.12.009","type":"journal-article","created":{"date-parts":[[2019,12,13]],"date-time":"2019-12-13T03:19:14Z","timestamp":1576207154000},"page":"253-268","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":27,"special_numbering":"C","title":["Crotoxin down-modulates pro-inflammatory cells and alleviates pain on the MOG35-55-induced experimental autoimmune encephalomyelitis, an animal model of multiple sclerosis"],"prefix":"10.1016","volume":"84","author":[{"given":"N.B.","family":"Teixeira","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.B.","family":"Sant'Anna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.C.","family":"Giardini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.P.","family":"Araujo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.A.","family":"Fonseca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.S.","family":"Basso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y.","family":"Cury","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Picolo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbi.2019.12.009_b0005","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1016\/j.pain.2004.03.025","article-title":"Hyperalgesia in an animal model of multiple sclerosis","volume":"110","author":"Aicher","year":"2004","journal-title":"Pain"},{"key":"10.1016\/j.bbi.2019.12.009_b0010","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0121427","article-title":"Crotoxin from Crotalus durissus terrificus is able to down-modulate the acute intestinal inflammation in mice","volume":"10","author":"Almeida","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.bbi.2019.12.009_b0015","doi-asserted-by":"crossref","DOI":"10.1037\/rep0000242","article-title":"Positive factors, pain, and function in adults with multiple sclerosis","author":"Arewasikporn","year":"2018","journal-title":"Rehabil. Psychol."},{"key":"10.1016\/j.bbi.2019.12.009_b0020","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1046\/j.1442-2026.2001.00174.x","article-title":"Venom as a source of useful biologically active molecules","volume":"13","author":"Bailey","year":"2001","journal-title":"Emerg. Med."},{"key":"10.1016\/j.bbi.2019.12.009_b0025","doi-asserted-by":"crossref","DOI":"10.1016\/0041-0101(91)90028-P","article-title":"Serum kinetics of crotoxin from Crotalus durissus terrificus venom in mice: evidence for a rapid clearance","author":"Barral-Netto","year":"1991","journal-title":"Toxicon"},{"key":"10.1016\/j.bbi.2019.12.009_b0030","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1172\/JCI33464","article-title":"Reversal of axonal loss and disability in a mouse model of progressive multiple sclerosis","volume":"118","author":"Basso","year":"2008","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bbi.2019.12.009_b0035","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1002\/jnr.24224","article-title":"Animal models of multiple sclerosis: focus on experimental autoimmune encephalomyelitis","volume":"96","author":"Bjelobaba","year":"2018","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.bbi.2019.12.009_b0040","doi-asserted-by":"crossref","first-page":"2457532","DOI":"10.1155\/2016\/2457532","article-title":"Walker 256 tumor growth suppression by crotoxin involves formyl peptide receptors and lipoxin A\u2084","volume":"2016","author":"Brigatte","year":"2016","journal-title":"Mediat. Inflamm."},{"issue":"Suppl. v3-9","key":"10.1016\/j.bbi.2019.12.009_b0045","article-title":"The pathology of multiple sclerosis is the result of focal inflammatory demyelination with axonal damage","volume":"252","author":"Br\u00fcck","year":"2005","journal-title":"J. Neurol."},{"key":"10.1016\/j.bbi.2019.12.009_b0050","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1080\/09629350124986","article-title":"Role of crotoxin, a phospholipase A2 isolated from Crotalus durissus terrificus snake venom, on inflammatory and immune reactions","volume":"10","author":"Cardoso","year":"2001","journal-title":"Mediat. Inflamm."},{"key":"10.1016\/j.bbi.2019.12.009_b0055","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.toxicon.2006.09.028","article-title":"The effect of treatment with crotapotin on the evolution of experimental autoimmune neuritis induced in Lewis rats","volume":"49","author":"Castro","year":"2007","journal-title":"Toxicon"},{"key":"10.1016\/j.bbi.2019.12.009_b0060","doi-asserted-by":"crossref","first-page":"2018","DOI":"10.1007\/s11064-010-0301-5","article-title":"Expression and signaling of formyl-peptide receptors in the brain","volume":"35","author":"Cattaneo","year":"2010","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.bbi.2019.12.009_b0065","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1124\/pr.58.3.4","article-title":"The lipoxin receptor ALX: potent ligand-specific and stereoselective actions in vivo","volume":"58","author":"Chiang","year":"2006","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.bbi.2019.12.009_b0070","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1016\/S0140-6736(08)61620-7","article-title":"Multiple sclerosis","volume":"372","author":"Compston","year":"2008","journal-title":"Lancet (London, England)"},{"key":"10.1016\/j.bbi.2019.12.009_b0075","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1111\/j.1476-5381.2011.01302.x","article-title":"Experimental autoimmune encephalomyelitis (EAE) as a model for multiple sclerosis (MS)","volume":"164","author":"Constantinescu","year":"2011","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.bbi.2019.12.009_b0080","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.toxicon.2013.08.057","article-title":"Involvement of formyl peptide receptors in the stimulatory effect of crotoxin on macrophages co-cultivated with tumour cells","volume":"74","author":"Costa","year":"2013","journal-title":"Toxicon"},{"key":"10.1016\/j.bbi.2019.12.009_b0085","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1136\/bmjopen-2013-004536","article-title":"Final results from the Betaseron (interferon \u03b2-1b) pregnancy registry: a prospective observational study of birth defects and pregnancy-related adverse events","volume":"4","author":"Coyle","year":"2014","journal-title":"BMJ Open"},{"key":"10.1016\/j.bbi.2019.12.009_b0090","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/j.it.2015.08.004","article-title":"GM-CSF in Neuroinflammation: licensing Myeloid Cells for Tissue Damage","volume":"36","author":"Croxford","year":"2015","journal-title":"Trends Immunol."},{"key":"10.1016\/j.bbi.2019.12.009_b0095","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1038\/tpj.2012.27","article-title":"Interferon-beta-1b-induced short- and long-term signatures of treatment activity in multiple sclerosis","volume":"13","author":"Croze","year":"2013","journal-title":"Pharmacogenomics J."},{"key":"10.1016\/j.bbi.2019.12.009_b0100","first-page":"401","article-title":"An electronic pressure-meter nociception paw test for mice. Brazilian J. Med. Biol. Res. = Rev","volume":"37","author":"Cunha","year":"2004","journal-title":"Bras. Pesqui. medicas e Biol."},{"key":"10.1016\/j.bbi.2019.12.009_b0105","first-page":"1033","article-title":"Phase I and pharmacokinetics study of crotoxin (cytotoxic PLA(2), NSC-624244) in patients with advanced cancer","volume":"8","author":"Cura","year":"2002","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.bbi.2019.12.009_b0110","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1358\/dnp.2006.19.7.985940","article-title":"Animal toxins as analgesics\u2013an overview","volume":"19","author":"Cury","year":"2006","journal-title":"Drug News Perspect."},{"key":"10.1016\/j.bbi.2019.12.009_b0115","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1016\/j.nut.2011.12.016","article-title":"Is multiple sclerosis a proresolution deficiency disorder?","volume":"28","author":"Das","year":"2012","journal-title":"Nutrition"},{"key":"10.1016\/j.bbi.2019.12.009_b0120","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1097\/AJP.0000000000000240","article-title":"An empirical investigation of a biopsychosocial model of pain in multiple sclerosis","volume":"32","author":"Day","year":"2016","journal-title":"Clin. J. Pain"},{"key":"10.1016\/j.bbi.2019.12.009_b0125","doi-asserted-by":"crossref","first-page":"145","DOI":"10.3389\/fphar.2018.00145","article-title":"Animal toxins as therapeutic tools to treat neurodegenerative diseases","volume":"9","author":"de Souza","year":"2018","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.bbi.2019.12.009_b0130","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1038\/nri3871","article-title":"Immunopathology of multiple sclerosis","volume":"15","author":"Dendrou","year":"2015","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.bbi.2019.12.009_b0135","doi-asserted-by":"crossref","DOI":"10.1038\/s41583-018-0053-9","article-title":"Multiple sclerosis and cognition: synaptic failure and network dysfunction","author":"Di Filippo","year":"2018","journal-title":"Nat. Rev. Neurosci"},{"key":"10.1016\/j.bbi.2019.12.009_b0140","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/ene.13819","article-title":"Multiple sclerosis - a review","volume":"26","author":"Dobson","year":"2019","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.bbi.2019.12.009_b0145","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.pharmthera.2010.04.010","article-title":"Therapeutic anti-inflammatory potential of formyl-peptide receptor agonists","volume":"127","author":"Dufton","year":"2010","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.bbi.2019.12.009_b0150","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1177\/1352458506071346","article-title":"The scope and nature of pain in persons with multiple sclerosis","volume":"12","author":"Ehde","year":"2006","journal-title":"Mult. Scler."},{"key":"10.1016\/j.bbi.2019.12.009_b0155","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/j.pmr.2005.01.001","article-title":"Chronic pain in persons with multiple sclerosis","volume":"16","author":"Ehde","year":"2005","journal-title":"Phys. Med. Rehabil. Clin. N. Am."},{"key":"10.1016\/j.bbi.2019.12.009_b0160","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.jns.2009.06.025","article-title":"Gender differences in multiple sclerosis: cytokines and vitamin D","volume":"286","author":"Eikelenboom","year":"2009","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.bbi.2019.12.009_b0165","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1007\/s40263-018-0488-6","article-title":"Efficacy and safety of the newer multiple sclerosis drugs approved since 2010","volume":"32","author":"Faissner","year":"2018","journal-title":"CNS Drugs"},{"key":"10.1016\/j.bbi.2019.12.009_b0170","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1021\/bi00402a036","article-title":"Crotoxin, a phospholipase A2 neurotoxin from the South American rattlesnake Crotalus durissus terrificus: purification of several isoforms and comparison of their molecular structure and of their biological activities","volume":"27","author":"Faure","year":"1988","journal-title":"Biochemistry"},{"key":"10.1016\/j.bbi.2019.12.009_b0175","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1016\/j.toxicon.2010.12.023","article-title":"Immunomodulatory effects of crotoxin isolated from Crotalus durissus terrificus venom in mice immunised with human serum albumin","volume":"57","author":"Favoretto","year":"2011","journal-title":"Toxicon"},{"key":"10.1016\/j.bbi.2019.12.009_b0180","doi-asserted-by":"crossref","first-page":"7873257","DOI":"10.1155\/2018\/7873257","article-title":"Crotoxin Isolated from crotalus durissus terrificus venom modulates the functional activity of dendritic cells via formyl peptide receptors","volume":"2018","author":"Freitas","year":"2018","journal-title":"J. Immunol. Res."},{"key":"10.1016\/j.bbi.2019.12.009_b0185","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1056\/NEJMra052130","article-title":"Multiple sclerosis\u2013the plaque and its pathogenesis","volume":"354","author":"Frohman","year":"2006","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bbi.2019.12.009_b0190","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/S0041-0101(03)00198-3","article-title":"Crotapotin induced modification of T lymphocyte proliferative response through interference with PGE2 synthesis","volume":"42","author":"Garcia","year":"2003","journal-title":"Toxicon"},{"key":"10.1016\/j.bbi.2019.12.009_b0195","doi-asserted-by":"crossref","first-page":"175","DOI":"10.2147\/DDDT.S8927","article-title":"Development of oral agent in the treatment of multiple sclerosis: how the first available oral therapy, fngolimod will change therapeutic paradigm approach","volume":"6","author":"Gasperini","year":"2012","journal-title":"Drug Des. Devel. Ther."},{"key":"10.1016\/j.bbi.2019.12.009_b0200","unstructured":"Gohil, K., 2015. Multiple Sclerosis: Progress, but No Cure., P & T\u00a0: a peer-reviewed journal for formulary management."},{"key":"10.1016\/j.bbi.2019.12.009_b0205","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1177\/1073858409360822","article-title":"Glial cells and chronic pain","volume":"16","author":"Gosselin","year":"2010","journal-title":"Neuroscientist"},{"key":"10.1016\/j.bbi.2019.12.009_b0210","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.1073\/pnas.68.7.1560","article-title":"Biological roles of the two components of crotoxin","volume":"68","author":"Hendon","year":"1971","journal-title":"Proc. Natl. Acad. Sci. U.S.A"},{"key":"10.1016\/j.bbi.2019.12.009_b0215","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.apmr.2008.10.019","article-title":"Prevalence and impact of pain in multiple sclerosis: physical and psychologic contributors","volume":"90","author":"Hirsh","year":"2009","journal-title":"Arch. Phys. Med. Rehabil."},{"key":"10.1016\/j.bbi.2019.12.009_b0220","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1002\/glia.20871","article-title":"Microglia and neuropathic pain","volume":"57","author":"Inoue","year":"2009","journal-title":"Glia"},{"key":"10.1016\/j.bbi.2019.12.009_b0225","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1038\/nm1651","article-title":"Human TH17 lymphocytes promote blood-brain barrier disruption and central nervous system inflammation","volume":"13","author":"Kebir","year":"2007","journal-title":"Nat. Med."},{"key":"10.1016\/j.bbi.2019.12.009_b0230","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1007\/s00401-011-0849-4","article-title":"Cholinergic imbalance in the multiple sclerosis hippocampus","volume":"122","author":"Kooi","year":"2011","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.bbi.2019.12.009_b0235","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jneuroim.2018.07.002","article-title":"Granulocyte-macrophage colony-stimulating factor as a mediator of autoimmunity in multiple sclerosis","volume":"323","author":"Kostic","year":"2018","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.bbi.2019.12.009_b0240","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1254\/jjp.27.117","article-title":"Effects of central depressants on rota-rod and traction performances in mice","volume":"27","author":"Kuribara","year":"1977","journal-title":"Jpn. J. Pharmacol."},{"key":"10.1016\/j.bbi.2019.12.009_b0245","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/S1471-4906(02)02316-5","article-title":"Formyl-peptide receptors revisited","volume":"23","author":"Le","year":"2002","journal-title":"Trends Immunol."},{"key":"10.1016\/j.bbi.2019.12.009_b0250","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1038\/nrd1197","article-title":"Therapeutic potential of venom peptides","volume":"2","author":"Lewis","year":"2003","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.bbi.2019.12.009_b0255","first-page":"S15","article-title":"Comparative efficacy and acceptability of disease-modifying therapies in patients with relapsing-remitting multiple sclerosis: a systematic review and network meta-analysis","volume":"55","author":"Li","year":"2019","journal-title":"J. Neurol."},{"key":"10.1016\/j.bbi.2019.12.009_b0260","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1038\/s41590-018-0135-x","article-title":"Reassessing B cell contributions in multiple sclerosis","volume":"19","author":"Li","year":"2018","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.bbi.2019.12.009_b0265","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.toxicon.2017.07.002","article-title":"Crotoxin, a rattlesnake toxin, down-modulates functions of bone marrow neutrophils and impairs the Syk-GTPase pathway","volume":"136","author":"Lima","year":"2017","journal-title":"Toxicon"},{"key":"10.1016\/j.bbi.2019.12.009_b0270","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.jneuroim.2011.12.018","article-title":"Rapamycin reduces clinical signs and neuropathic pain in a chronic model of experimental autoimmune encephalomyelitis","volume":"243","author":"Lisi","year":"2012","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.bbi.2019.12.009_b0275","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1016\/0041-0101(87)90136-X","article-title":"Determination of phospholipase A2 activity by a colorimetric assay using a pH indicator","volume":"25","author":"L\u00f4bo de Ara\u00fajo","year":"1987","journal-title":"Toxicon"},{"key":"10.1016\/j.bbi.2019.12.009_b0280","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/S0022-1759(00)00231-3","article-title":"Analysing cell division in vivo and in vitro using flow cytometric measurement of CFSE dye dilution","volume":"243","author":"Lyons","year":"2000","journal-title":"J. Immunol. Meth."},{"key":"10.1016\/j.bbi.2019.12.009_b0285","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1111\/j.1432-1033.1982.tb06663.x","article-title":"Relationship between the pharmacological action of crotoxin and its phospholipase activity","volume":"125","author":"Marlas","year":"1982","journal-title":"Eur. J. Biochem."},{"key":"10.1016\/j.bbi.2019.12.009_b0290","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1146\/annurev.iy.10.040192.001101","article-title":"Immunological aspects of demyelinating diseases","volume":"10","author":"Martin","year":"1992","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.bbi.2019.12.009_b0295","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1084\/jem.194.7.873","article-title":"Granulocyte macrophage colony-stimulating factor: a new putative therapeutic target in multiple sclerosis","volume":"194","author":"McQualter","year":"2001","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.bbi.2019.12.009_b0300","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.conctc.2017.07.008","article-title":"Innovative design for a phase 1 trial with intra-patient dose escalation: the Crotoxin study","volume":"7","author":"Medioni","year":"2017","journal-title":"Contemp. Clin. trials Commun."},{"key":"10.1016\/j.bbi.2019.12.009_b0305","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1038\/nrn2533","article-title":"Pathological and protective roles of glia in chronic pain","volume":"10","author":"Milligan","year":"2009","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.bbi.2019.12.009_b0310","unstructured":"Multiple Sclerosis International Federation [WWW Document], 2018. URL https:\/\/www.msif.org\/about-ms\/what-is-ms\/. (Accessed 10.2.18)."},{"key":"10.1016\/j.bbi.2019.12.009_b0315","first-page":"712","article-title":"Multiple sclerosis","volume":"87","author":"Nicholas","year":"2013","journal-title":"Am. Fam. Physician"},{"key":"10.1016\/j.bbi.2019.12.009_b0320","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1179\/1743132812Y.0000000082","article-title":"Multiple sclerosis and pain","volume":"34","author":"Nick","year":"2012","journal-title":"Neurol. Res."},{"key":"10.1016\/j.bbi.2019.12.009_b0325","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.pbb.2008.08.016","article-title":"The analgesic effect of crotoxin on neuropathic pain is mediated by central muscarinic receptors and 5-lipoxygenase-derived mediators","volume":"91","author":"Nogueira-Neto","year":"2008","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.bbi.2019.12.009_b0330","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1016\/j.toxicon.2009.12.011","article-title":"Crotoxin is responsible for the long-lasting anti-inflammatory effect of Crotalus durissus terrificus snake venom: involvement of formyl peptide receptors","volume":"55","author":"Nunes","year":"2010","journal-title":"Toxicon"},{"key":"10.1016\/j.bbi.2019.12.009_b0335","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S0022-3565(25)38138-3","article-title":"Induction of tolerance to crotoxin in mice","volume":"265","author":"Okamoto","year":"1993","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.bbi.2019.12.009_b0340","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/j.pain.2010.03.037","article-title":"A diminished response to formalin stimulation reveals a role for the glutamate transporters in the altered pain sensitivity of mice with experimental autoimmune encephalomyelitis (EAE)","volume":"149","author":"Olechowski","year":"2010","journal-title":"Pain"},{"key":"10.1016\/j.bbi.2019.12.009_b0345","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.pain.2006.07.017","article-title":"Psychosocial factors associated with pain intensity, pain-related interference, and psychological functioning in persons with multiple sclerosis and pain","volume":"127","author":"Osborne","year":"2007","journal-title":"Pain"},{"key":"10.1016\/j.bbi.2019.12.009_b0350","doi-asserted-by":"crossref","unstructured":"Paty, D., Ebers, G., 1999. Multiple Sclerosis. Philadelphia.","DOI":"10.1038\/15430"},{"key":"10.1016\/j.bbi.2019.12.009_b0355","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.1093\/brain\/awf165","article-title":"Markers for different glial cell responses in multiple sclerosis: clinical and pathological correlations","volume":"125","author":"Petzold","year":"2002","journal-title":"Brain"},{"key":"10.1016\/j.bbi.2019.12.009_b0360","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1111\/j.1600-065X.2012.01126.x","article-title":"Mechanisms regulating regional localization of inflammation during CNS autoimmunity","volume":"248","author":"Pierson","year":"2012","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.bbi.2019.12.009_b0365","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/j.toxicon.2004.07.004","article-title":"Immunosuppresive role of principal toxin (crotoxin) of Crotalus durissus terrificus venom","volume":"44","author":"Rangel-Santos","year":"2004","journal-title":"Toxicon"},{"key":"10.1016\/j.bbi.2019.12.009_b0370","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1056\/NEJMra1401483","article-title":"Multiple sclerosis","volume":"378","author":"Reich","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bbi.2019.12.009_b0375","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1590\/S0004-282X2009000100019","article-title":"Mechanical hypernociception in experimental autoimmune encephalomyelitis","volume":"67","author":"Rodrigues","year":"2009","journal-title":"Arq. Neuropsiquiatr."},{"key":"10.1016\/j.bbi.2019.12.009_b0380","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1590\/S0004-282X2012000900016","article-title":"Physiopathology of symptoms and signs in multiple sclerosis","volume":"70","author":"S\u00e1","year":"2012","journal-title":"Arq. Neuropsiquiatr."},{"key":"10.1016\/j.bbi.2019.12.009_b0385","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.toxicon.2005.11.008","article-title":"Lipoxygenase-derived eicosanoids are involved in the inhibitory effect of Crotalus durissus terrificus venom or crotoxin on rat macrophage phagocytosis","volume":"47","author":"Sampaio","year":"2006","journal-title":"Toxicon"},{"key":"10.1016\/j.bbi.2019.12.009_b0390","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1016\/S0041-0101(03)00069-2","article-title":"Contribution of crotoxin for the inhibitory effect of Crotalus durissus terrificus snake venom on macrophage function","volume":"41","author":"Sampaio","year":"2003","journal-title":"Toxicon"},{"key":"10.1016\/j.bbi.2019.12.009_b0395","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1016\/j.toxicon.2010.01.011","article-title":"Crotoxin: novel activities for a classic beta-neurotoxin","volume":"55","author":"Sampaio","year":"2010","journal-title":"Toxicon"},{"key":"10.1016\/j.bbi.2019.12.009_b0400","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/j.toxicon.2005.01.009","article-title":"Inhibitory effect of phospholipase A2 isolated from Crotalus durissus terrificus venom on macrophage function","volume":"45","author":"Sampaio","year":"2005","journal-title":"Toxicon"},{"key":"10.1016\/j.bbi.2019.12.009_b0405","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1016\/j.toxicon.2006.03.004","article-title":"Crotoxin induces actin reorganization and inhibits tyrosine phosphorylation and activity of small GTPases in rat macrophages","volume":"47","author":"Sampaio","year":"2006","journal-title":"Toxicon"},{"issue":"1537\u20132073","key":"10.1016\/j.bbi.2019.12.009_b0410","first-page":"2018","article-title":"Fingolimod and Cryptococcosis: collision of Immunomodulation with Infectious Disease","volume":"23","author":"Samudralwar","year":"2019","journal-title":"Int. J. MS Care"},{"key":"10.1016\/j.bbi.2019.12.009_b0415","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1111\/j.1755-5949.2011.00249.x","article-title":"Muscarinic receptors: their roles in disorders of the central nervous system and potential as therapeutic targets","volume":"18","author":"Scarr","year":"2012","journal-title":"CNS Neurosci. Ther."},{"key":"10.1016\/j.bbi.2019.12.009_b0420","doi-asserted-by":"crossref","first-page":"1987","DOI":"10.1093\/pm\/pnw290","article-title":"Pain and cognition in multiple sclerosis","volume":"18","author":"Scherder","year":"2017","journal-title":"Pain Med."},{"key":"10.1016\/j.bbi.2019.12.009_b0425","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1038\/nn1992","article-title":"The neuropathic pain triad: neurons, immune cells and glia","volume":"10","author":"Scholz","year":"2007","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.bbi.2019.12.009_b0430","first-page":"109","article-title":"Current concepts in multiple sclerosis therapy","volume":"7","author":"Sedal","year":"2017","journal-title":"Degener. Neurol. Neuromuscul. Dis."},{"key":"10.1016\/j.bbi.2019.12.009_b0435","first-page":"244","article-title":"Impairment, disability and fatigue in multiple sclerosis","volume":"9","author":"Shahrbanian","year":"2018","journal-title":"Casp. J. Intern. Med."},{"key":"10.1016\/j.bbi.2019.12.009_b0440","doi-asserted-by":"crossref","first-page":"553","DOI":"10.3389\/fimmu.2017.00553","article-title":"Autophagy plays an important role in anti-inflammatory mechanisms stimulated by Alpha7 nicotinic acetylcholine receptor","volume":"8","author":"Shao","year":"2017","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bbi.2019.12.009_b0445","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0187857","article-title":"Multiple effects of toxins isolated from Crotalus durissus terrificus on the hepatitis C virus life cycle","volume":"12","author":"Shimizu","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.bbi.2019.12.009_b0450","doi-asserted-by":"crossref","first-page":"504","DOI":"10.3109\/08916931003674733","article-title":"Pathogenic mechanisms and experimental models of multiple sclerosis","volume":"43","author":"Slavin","year":"2010","journal-title":"Autoimmunity"},{"key":"10.1016\/j.bbi.2019.12.009_b0455","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1016\/j.bbi.2008.09.004","article-title":"Anti-inflammatory cytokine gene therapy decreases sensory and motor dysfunction in experimental Multiple Sclerosis: MOG-EAE behavioral and anatomical symptom","volume":"23","author":"Sloane","year":"2009","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.bbi.2019.12.009_b0460","doi-asserted-by":"crossref","DOI":"10.1007\/s40264-019-00799-1","article-title":"Established and emerging immunological complications of biological therapeutics in multiple sclerosis","author":"Soleimani","year":"2019","journal-title":"Drug Saf."},{"key":"10.1016\/j.bbi.2019.12.009_b0465","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1038\/nm1551","article-title":"A brief history of TH17, the first major revision in the TH1\/TH2 hypothesis of T cell-mediated tissue damage","volume":"13","author":"Steinman","year":"2007","journal-title":"Nat. Med."},{"key":"10.1016\/j.bbi.2019.12.009_b0470","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1084\/jem.20061826","article-title":"Lipoxins and aspirin-triggered lipoxin inhibit inflammatory pain processing","volume":"204","author":"Svensson","year":"2007","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.bbi.2019.12.009_b0475","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1111\/j.1600-0404.2006.00749.x","article-title":"Chemokines and chemokine receptors in multiple sclerosis. Potential targets for new therapies","volume":"115","author":"Szczuci\u0144ski","year":"2007","journal-title":"Acta Neurol. Scand."},{"key":"10.1016\/j.bbi.2019.12.009_b0480","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.bbi.2014.09.020","article-title":"VPAC2 (vasoactive intestinal peptide receptor type 2) receptor deficient mice develop exacerbated experimental autoimmune encephalomyelitis with increased Th1\/Th17 and reduced Th2\/Treg responses","volume":"44","author":"Tan","year":"2015","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.bbi.2019.12.009_b0485","first-page":"S15","article-title":"Recent advances in the treatment for multiple sclerosis; current new drugs specific for multiple sclerosis","volume":"55","author":"Taskapilioglu","year":"2018","journal-title":"Noro Psikiyatr. Ars."},{"key":"10.1016\/j.bbi.2019.12.009_b0490","doi-asserted-by":"crossref","first-page":"231.e1","DOI":"10.1016\/j.ejpain.2010.07.010","article-title":"Characterisation of sensory abnormalities observed in an animal model of multiple sclerosis: a behavioural and pharmacological study","volume":"15","author":"Thibault","year":"2011","journal-title":"Eur. J. Pain"},{"key":"10.1016\/j.bbi.2019.12.009_b0495","doi-asserted-by":"crossref","first-page":"213","DOI":"10.9740\/mhc.2017.09.213","article-title":"What\u2019s new in multiple sclerosis?","volume":"7","author":"Tillery","year":"2017","journal-title":"Ment. Heal. Clin."},{"key":"10.1016\/j.bbi.2019.12.009_b0500","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.jns.2009.07.016","article-title":"Early onset multiple sclerosis: the role of gender","volume":"286","author":"Tintor\u00e9","year":"2009","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.bbi.2019.12.009_b0505","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/1744-9081-5-11","article-title":"Evaluation of animal models of neurobehavioral disorders","volume":"5","author":"van der Staay","year":"2009","journal-title":"Behav. Brain Funct."},{"key":"10.1016\/j.bbi.2019.12.009_b0510","doi-asserted-by":"crossref","first-page":"8692","DOI":"10.1523\/JNEUROSCI.23-25-08692.2003","article-title":"Interleukin-1\u03b2 enhances NMDA receptor-mediated intracellular calcium increase through activation of the Src family of kinases","volume":"23","author":"Viviani","year":"2003","journal-title":"J. Neurosci."},{"key":"10.1016\/j.bbi.2019.12.009_b0515","doi-asserted-by":"crossref","first-page":"2047","DOI":"10.1016\/S0024-3205(03)00082-1","article-title":"Muscarinic receptor subtypes mediating central and peripheral antinociception studied with muscarinic receptor knockout mice: a review","volume":"72","author":"Wess","year":"2003","journal-title":"Life Sci."},{"key":"10.1016\/j.bbi.2019.12.009_b0520","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.toxicon.2013.07.019","article-title":"Antinociceptive activity of crotoxin in the central nervous system: a functional Magnetic Resonance Imaging study","volume":"74","author":"Wolz-Richter","year":"2013","journal-title":"Toxicon"},{"key":"10.1016\/j.bbi.2019.12.009_b0525","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1007\/s11481-012-9370-3","article-title":"Wnt signaling in the pathogenesis of multiple sclerosis-associated chronic pain","volume":"7","author":"Yuan","year":"2012","journal-title":"J. Neuroimmune Pharmacol."},{"key":"10.1016\/j.bbi.2019.12.009_b0530","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1016\/j.toxicon.2008.03.004","article-title":"Crotoxin alters lymphocyte distribution in rats: involvement of adhesion molecules and lipoxygenase-derived mediators","volume":"51","author":"Zambelli","year":"2008","journal-title":"Toxicon"},{"key":"10.1016\/j.bbi.2019.12.009_b0535","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.jneuroim.2013.09.019","article-title":"MicroRNA-155 modulates Th1 and Th17 cell differentiation and is associated with multiple sclerosis and experimental autoimmune encephalomyelitis","volume":"266","author":"Zhang","year":"2014","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.bbi.2019.12.009_b0540","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/0304-3959(83)90201-4","article-title":"Ethical guidelines for investigations of experimental pain in conscious animals","volume":"16","author":"Zimmermann","year":"1983","journal-title":"Pain"}],"container-title":["Brain, Behavior, and Immunity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889159119303769?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889159119303769?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T07:57:19Z","timestamp":1760169439000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0889159119303769"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2]]},"references-count":108,"alternative-id":["S0889159119303769"],"URL":"https:\/\/doi.org\/10.1016\/j.bbi.2019.12.009","relation":{},"ISSN":["0889-1591"],"issn-type":[{"value":"0889-1591","type":"print"}],"subject":[],"published":{"date-parts":[[2020,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Crotoxin down-modulates pro-inflammatory cells and alleviates pain on the MOG35-55-induced experimental autoimmune encephalomyelitis, an animal model of multiple sclerosis","name":"articletitle","label":"Article Title"},{"value":"Brain, Behavior, and Immunity","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbi.2019.12.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc.","name":"copyright","label":"Copyright"}]}}